Rasha Al-Lamee, MD, on the sequel to the controversial stent vs sham trial
With ORBITA-2, percutaneous coronary intervention (PCI) gets a second chance to prove it's better than placebo for symptom relief in stable angina after the first randomized sham-controlled trial of stenting came out negative.